Global Pharmatech, Inc.
GBLP · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -4.7% | -82.1% | 27.5% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 51.2% | -20.1% | 13.5% | 4.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -22.9% | -94.8% | -0.1% | -29.4% |
| Other Income/Exp. Net | $0 | -$0 | -$0 | $0 |
| Pre-Tax Income | $0 | -$0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 18.2% | -95.3% | -0.3% | -28.9% |
| EPS | 0 | -0 | 0 | -0 |
| % Growth | 100% | – | 100% | – |
| EPS Diluted | 0 | -0 | 0 | -0 |
| Weighted Avg Shares Out | 415 | 405 | 395 | 395 |
| Weighted Avg Shares Out Dil | 415 | 405 | 395 | 395 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | -$0 | $0 |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 25.3% | -66.8% | -0.1% | -28.3% |